Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Ann L. Daugherty, Ph.D. is currently a Senior Manager in the Drug Delivery department at Genentech. She identifies promising external delivery technologies for application to Genentech’s pipeline of protein drugs, setting up feasibility study agreements as well as managing relationships and projects with technology partners. A biopharmaceutical scientist with training and experience in pharmacokinetics and biocompatibility, Dr. Daugherty’s interests are in integrating all of the various aspects of drug delivery to provide an optimized product to patients.
In addition to studying ocular delivery for the past decade, Ann has studied alternative routes of administration for protein drugs such as oral, pulmonary, nasal and even transdermal delivery, as well as investigating delivery to the CNS. Prior to joining Genentech, she worked at Alza, the first drug delivery company working on delivery systems with controlled delivery of small molecules given orally or by transdermal patches